Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Enzyme protein eight times more effective against pain than morphine

09.10.2008
More people suffer from pain than from heart diseases, diabetes or cancer combined. Research teams at the University of Helsinki and the University of North Carolina have discovered a new powerful painkiller that has shown no side effects in mouse testing.

The enzyme protein found naturally in the body alleviated pain eight times more effectively than morphine. Research findings are published this week as the cover story of the esteemed Neuron journal.

Professor Pirkko Vihko from the Department of Biological and Environmental Sciences of the University of Helsinki has conducted research on the Prostatic Acid Phosphatase (PAP) enzyme for more than 30 years. As the name indicates, the prostate contains plenty of this enzyme.

Last year, Vihko's research team described the membrane form of the enzyme and showed that it is present not only in the prostate, but in many other cells and organs as well. The PAP enzyme exists, for example, in pain-sensing nerves, but it has disappeared from damaged nerves.

For the research project presented in the Neuron journal, Vihko and her team prepared a knockout mouse model with the PAP enzyme knocked out. Together with Mark Zylka's team from the University of North Carolina they showed that these mice had an increased sensitivity for pain caused by inflammation and neural damage. The reason for the sensitivity was the lack of the PAP enzyme. Enzyme protein replacement treatment removed pain effectively – eight times more so than morphine. Clinical research will begin next.

Research teams also determined the mechanism that the acid phosphatase of the prostate uses to regulate pain alleviation. In an organism, the enzyme generates adenosine that controls the experience of pain through the adenosine receptor. Vihko’s team will prepare new publications that describe the entirely new effective areas of the enzyme.

Kirsikka Mattila | alfa
Further information:
http://www.neuron.org/

Further reports about: Cancer Diabetes Enzym Enzyme protein Neuron Painkiller morphine prostate

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>